FDA to Ban JUUL E-Cigarettes Over Youth Appeal

Jun.24.2022
The FDA prohibits JUUL e-cigarettes due to concerns about their impact on youth vaping. Nicotine is highly addictive and dangerous for teens.

The US Food and Drug Administration (FDA) announced today that it will ban the sale of JUUL e-cigarettes, citing the company's significant role in the popularity of youth e-cigarette use. Critics argue that JUUL's aggressive marketing tactics have led more teenagers to take up vaping. Public health experts warn that e-cigarettes are unsafe for youth, children, and young adults, as they contain nicotine, a highly addictive substance. Studies have also shown that exposure to nicotine during adolescence can lead to persistent behavioral problems, higher anxiety rates, and impulse control issues.

 

According to Adnan Hyder, Director of the Health and Business Decision-making Center at George Washington University and Senior Associate Dean for Public Health at the GW Milken Institute School of Public Health, the e-cigarette industry is taking advantage of the vulnerability of young people and exposing them to health risks. Hyder observed that the industry is using tactics commonly used by the tobacco industry, such as attacking regulations, promoting controversial evidence, promoting distrust, and utilizing marketing strategies like social media and advertising. He welcomed the FDA's decision and hopes that more regulations and restrictions on nicotine and tobacco products will follow.

 

Nino Paichadze, the Deputy Director and Expert on Health Business Determinants at the center states: "Electronic cigarettes are a rapidly emerging and diversified product category, particularly appealing to young adults and teens. As of 2021, over two million American middle and high school students reported currently using e-cigarettes. JUUL is just one of many e-cigarettes that contain high levels of nicotine, which is harmful to the developing brains of teens and can lead to numerous adverse health conditions. The company has been strategically marketing their products, taking advantage of the innocence and independence of young people. Given that young adults and teens are a crucial stage in human development, and considering the alarming statistics on e-cigarette use among American youth, the FDA's decision is both timely and necessary. This is a major victory for public health today!

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

BAT Podcast with AACS CEO: Vape Policy Imbalance Fuels Australia’s Billion-Dollar Illicit Market
BAT Podcast with AACS CEO: Vape Policy Imbalance Fuels Australia’s Billion-Dollar Illicit Market
In BAT’s The Smokeless Word podcast, AACS CEO Theo Foukkare warned that high taxes and strict vape bans have fueled Australia’s AUD 10-billion illicit nicotine market and rising retail crime, urging urgent regulatory reform.
Oct.27 by 2FIRSTS.ai
South Korea’s Parliament Reconsiders Bill to Regulate Synthetic Nicotine as Tobacco
South Korea’s Parliament Reconsiders Bill to Regulate Synthetic Nicotine as Tobacco
South Korea’s National Assembly is once again reviewing a bill to classify synthetic nicotine as a tobacco product under the Tobacco Business Act. The proposal aims to close regulatory loopholes that allow untaxed, unregulated nicotine liquids — often used by minors — to circulate freely. Lawmakers expect the bill to pass during the current session amid growing public and civic pressure.
Nov.26 by 2FIRSTS.ai
Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment
Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment
Imperial Brands has launched its ZONE nicotine pouches in the UK, targeting the mainstream 9–12 mg nicotine strength segment. The brand debuts with five flavours at a recommended retail price of £6.50 per can. Mint variants currently account for around 70% of UK nicotine pouch sales, while fruit flavours are growing rapidly. ZONE will be distributed primarily through independent retail channels.
Nov.18 by 2FIRSTS.ai
ceshi
ceshi
Nov.04
Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes
Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes
Belgium’s drug commissioner Ine Van Wymersch has warned that more than 80% of illegal refillable vape capsules seized in Belgium contain synthetic opioids, posing serious risks of early addiction among children. She told Euronews that these substances, which have no distinctive smell or color, could lead to opioid dependence from a young age.
Dec.08 by 2FIRSTS.ai
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04